학술논문
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
Document Type
Article
Author
Akil, Mohammed; Babalis, Daphne; Chaudhuri, Nazia; Chua, Felix; Data, Arnab; Desai, Dhananjay; Dubey, Shrish; Dwyer, Natalie; Flather, Marcus; Fordham, Richard; Grossi Sampedro, Carlota; Hall, Frances; Jakupovic, Ira; Keir, Gregory; Patel, Bipen; Penn, Henry; Rajasekaran, Arvind; Spencer, Lisa G; Tsipouri, Vicky; Wu, Zhe; Xydopoulos, Georgio; Zanghelini, Fernando; Maher, Toby M ; Tudor, Veronica A; Saunders, Peter; Gibbons, Michael A; Fletcher, Sophie V; Denton, Christopher P; Hoyles, Rachel K; Parfrey, Helen; Renzoni, Elisabetta A; Kokosi, Maria; Wells, Athol U; Ashby, Deborah; Szigeti, Matyas; Molyneaux, Philip L
Source
In The Lancet Respiratory Medicine January 2023 11(1):45-54
Subject
Language
ISSN
2213-2600